Interruption of KLF5 acetylation promotes PTEN-deficient prostate cancer progression by reprogramming cancer-associated fibroblasts.
Zhang B, Liu M, Mai F, Li X, Wang W, Huang Q, Du X, Ding W, Li Y, Barwick BG, Ni JJ, Osunkoya AO, Chen Y, Zhou W, Xia S, Dong JT.
Zhang B, et al. Among authors: dong jt.
J Clin Invest. 2024 May 23;134(14):e175949. doi: 10.1172/JCI175949.
J Clin Invest. 2024.
PMID: 38781024
Free PMC article.